|
|
Constitutive and B-cell receptor-induced activation of STAT3 are important signaling pathways targeted by bortezomib in leukemic mantle cell lymphoma
F. Baran-Marszak
,
M. Boukhiar
,
S. Harel
,
C. Laguillier
,
C. Roger
et al.
Article dans une revue
hal-03945121v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY
Larry Mansouri
,
Birna Thorvaldsdottir
,
Lesley-Ann Sutton
,
Georgios Karakatsoulis
,
Manja Meggendorfer
et al.
Article dans une revue
hal-03942448v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Different Prognostic Impact of Recurrent Gene Mutations in IGHV-Mutated and IGHV-Unmutated Chronic Lymphocytic Leukemia: A Retrospective, Multi-Center Cohort Study By Eric, the European Research Initiative on CLL, in Harmony
Larry Mansouri
,
Birna Thorvaldsdottir
,
Lesley-Ann Sutton
,
Manja Meggendorfer
,
Ferran Nadeu
et al.
Communication dans un congrès
inserm-03950165v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Prevalence, distribution and predictive value of XPO1 mutation in a real‐life chronic lymphocytic leukaemia cohort
Giulia Tueur
,
Gregory Lazarian
,
Virginie Eclache
,
Carole Fleury
,
Rémi Letestu
et al.
Article dans une revue
hal-03942496v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact
Panagiotis Baliakas
,
Sabine Jeromin
,
Michalis Iskas
,
Anna Puiggros
,
Karla Plevova
et al.
Article dans une revue
hal-03946254v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
An Axis Involving beta-Catenin and BTK Controls the Interaction with the Microenvironment in CLL
Souhail Ouriemmi
,
Tareck Rharass
,
Grégory Lazarian
,
Valérie Gratio
,
Christine Le Roy
et al.
5th International Conference New Concepts In Lymphoid Malignancies, Oct 2019, ESTORIL, Portugal
Poster de conférence
hal-03944836v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Down-regulation of CXCR4 and CD62L in Chronic Lymphocytic Leukemia Cells Is Triggered by B-Cell Receptor Ligation and Associated with Progressive Disease
Amalia Vlad
,
Pierre-Antoine Deglesne
,
Rémi Letestu
,
Stéphane Saint-Georges
,
Nathalie Chevallier
et al.
Article dans une revue
hal-03945133v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Démarche théranostique dans la LLC : Quel apport de la recherche des mutations de différents gènes de la voie de p53 par NGS ?
G Tueur
,
V Eclache
,
G Lazarian
,
C Fleury
,
R Letestu
et al.
Congrès de la Société Française d’Hématologie, Mar 2019, PARIS, France
Communication dans un congrès
hal-03966314v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Profil des mutations de TP53 dans la Leucémie Lymphoïde Chronique (LLC) : une étude FILO
F Baran-Marszak
,
L Véronèse
,
P Sujobert
,
A Bidet
,
F Davi
et al.
Congrès de la Société Française d’Hématologie, Sep 2017, PARIS, France
Poster de conférence
hal-03968400v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A STAT3-inhibitory hairpin decoy oligodeoxynucleotide discriminates between STAT1 and STAT3 and induces death in a human colon carcinoma cell line.
Inès Souissi
,
Patrick Ladam
,
Jean Cognet
,
Stéphanie Le Coquil
,
Nadine Varin-Blank
et al.
Article dans une revue
inserm-00687513v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Inhibitors of BCR signalling interrupt the survival signal mediated by the micro-environment in mantle cell lymphoma
Sophie Bernard
,
Damien Danglade
,
Laura Gardano
,
Christelle Laguillier
,
Gregory Lazarian
et al.
Article dans une revue
hal-03944897v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Relapse of acquired von Willebrand syndrome in a patient non-compliant with Crohn's disease
Myriam Hormi
,
Melchior Le Méné
,
Céline Comparon
,
Imededdine El Kout
,
Fanny Baran-Marszak
et al.
Autre publication scientifique
hal-03893004v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
TP53, XPO1 and ATM Mutations Exclusive Distribution in the Adverse Prognosis Chronic Lymphocytic Leukemia (CLL) Group
Giulia Tueur
,
Virginie Eclache
,
Grégory Lazarian
,
Carole Fleury
,
Rémi Letestu
et al.
Poster de conférence
hal-03965966v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Stabilization of β-catenin upon B-cell receptor signaling promotes NF-kB target genes transcription in mantle cell lymphoma
Gregory Lazarian
,
Chloe Friedrich
,
Anne Quinquenel
,
Julie Tran
,
Souhail Ouriemmi
et al.
Article dans une revue
inserm-02534412v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Impact of Low-Burden TP53 Mutations in the Management of CLL
Gregory Lazarian
,
Florence Cymbalista
,
Fanny Baran-Marszak
Article dans une revue
hal-03942466v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
The AXL tyrosine kinase inhibitor, BGB324, induces cell death in mantle cell lymphoma
P Gelebart
,
J Han
,
I Karlsen
,
M E Gjerstad
,
L Helgeland
et al.
European Hematology Association, Jun 2018, STOCKHLOM, Sweden
Poster de conférence
hal-03968396v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Les mutations de TP53 au codon 234 sont associées au traitement par chlorambucil dans la Leucémie Lymphoïde Chronique
Gregory Lazarian
,
F Theves
,
M Hormi
,
R Letestu
,
V Eclache
et al.
Congrès annuel de la Société Française d’Hématologie, Nov 2022, PARIS, France
Poster de conférence
hal-03968447v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
LEUKEMIEA CUTIS IN CHRONIC LYMPHOCYTIC LEUKEMIA: A RETROSPECTIVE STUDY of the French Innovative Leumkemia organization (FILO)
Gregory Lazarian
,
M Munger
,
A Quinquenel
,
M Dilhuydy
,
L Veronese
et al.
EHA, Jun 2021, PARIS, France
Poster de conférence
hal-03968460v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY
Larry Mansouri
,
Birna Thorvaldsdottir
,
Lesley-Ann Sutton
,
Georgios Karakatsoulis
,
Manja Meggendorfer
et al.
Article dans une revue
hal-03942442v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Improvement of Standardization of Molecular Analyses in Hematology: The 10-year GBMHM French Experience
Anne Sophie Alary
,
Carole Maute
,
Olivier Kosmider
,
Pierre Sujobert
,
Audrey Gauthier
et al.
Article dans une revue
hal-03464576v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Prevalence of BTK and PLCG2 mutations in a real-life CLL cohort still on ibrutinib after 3 years: a FILO group study
Anne Quinquenel
,
Luc-Matthieu Fornecker
,
Remi Letestu
,
Loic Ysebaert
,
Carole Fleury
et al.
Article dans une revue
hal-02301308v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Immuno-regulatory malignant B cells contribute to Chronic Lymphocytic Leukemia progression
Arsène Mékinian
,
Anne Quinquenel
,
Koceila Ait Belkacem
,
Fériel Kanoun
,
Elisabetta Dondi
et al.
2022
Pré-publication, Document de travail
hal-03966227v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
CLL-240 Frequency of IKZF3 L162R Mutation in B-Cell Lymphoproliferative Disorders
Assia Taleb
,
Carole Fleury
,
Florence Cymbalista
,
Fanny Baran-Marszak
,
Gregory Lazarian
et al.
Poster de conférence
inserm-03950175v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Dihydroorotate dehydrogenase inhibition acts synergistically with tyrosine kinase inhibitors to induce apoptosis of mantle cell lymphoma cells
May Eriksen-Gjerstad
,
Ida Tveit Karlsen
,
Zinayida Fandalyuk
,
Susanne Benjaminsen
,
Fanny Baran-Marszak
et al.
Article dans une revue
inserm-03950084v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A primitive plasma cell leukemia with immunoglobulin (Ig) E
Meriem Rachidi
,
Gregory Lazarian
,
Rémi Letestu
,
Daniel Lusina
,
Cedric Desbene
et al.
Autre publication scientifique
hal-03942510v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Microenvironment education by tumor cells in Chronic Lymphocytic Leukemia: a metabolic and morphological perspective
Jordan Ferreira
,
Imane Mihoub
,
Antonin Oudar
,
Gregory Lazarian
,
Fanny Baran-Marszak
et al.
5th International Cancer Symposium, Nov 2022, LYON, France
Poster de conférence
hal-03944870v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
High Prevalence of BTK Mutations on Ibrutinib Therapy after 3 Years of Treatment in a Real-Life Cohort of CLL Patients: A Study from the French Innovative Leukemia Organization (FILO) Group
Anne Quinquenel
,
Luc Matthieu Fornecker
,
Remi Letestu
,
Carole Fleury
,
Loic Ysebaert
et al.
Communication dans un congrès
hal-03965861v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Outcomes and mutational analysis of patients with lower-risk non-del5q myelodysplastic syndrome treated with antithymocyte globulin with or without ciclosporine A
C. Kelaidi
,
T. Braun
,
R. Arana
,
A. Marceau-Renaut
,
G. Lazarian
et al.
Article dans une revue
hal-03966154v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
High Frequency of Mutations in BTK and PLCG2 in Chronic Lymphocytic Leukemia (CLL) Patients on Ibrutinib Therapy
Carole Fleury
,
Anne Quinquenel
,
Luc-Matthieu Fornecker
,
Loïc Ysebaert
,
Catherine Thieblemont
et al.
Poster de conférence
hal-03965956v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice
Bernard Leroy
,
Mandy L Ballinger
,
Fanny Baran-Marszak
,
Gareth L Bond
,
Antony Braithwaite
et al.
Article dans une revue
hal-02343459v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|